vs
Side-by-side financial comparison of AGENUS INC (AGEN) and BayCom Corp (BCML). Click either name above to swap in a different company.
AGENUS INC is the larger business by last-quarter revenue ($34.2M vs $25.9M, roughly 1.3× BayCom Corp). BayCom Corp runs the higher net margin — 26.5% vs -31.0%, a 57.5% gap on every dollar of revenue. On growth, AGENUS INC posted the faster year-over-year revenue change (27.5% vs 9.4%). Over the past eight quarters, AGENUS INC's revenue compounded faster (10.5% CAGR vs 2.9%).
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.
BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.
AGEN vs BCML — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.2M | $25.9M |
| Net Profit | $-10.6M | $6.9M |
| Gross Margin | — | — |
| Operating Margin | 42.1% | 36.6% |
| Net Margin | -31.0% | 26.5% |
| Revenue YoY | 27.5% | 9.4% |
| Net Profit YoY | 77.3% | 12.1% |
| EPS (diluted) | $0.09 | $0.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.2M | $25.9M | ||
| Q3 25 | $30.2M | $25.7M | ||
| Q2 25 | $25.7M | $24.7M | ||
| Q1 25 | $24.1M | $24.3M | ||
| Q4 24 | $26.8M | $23.7M | ||
| Q3 24 | $25.1M | $25.6M | ||
| Q2 24 | $23.5M | $23.8M | ||
| Q1 24 | $28.0M | $24.5M |
| Q4 25 | $-10.6M | $6.9M | ||
| Q3 25 | $63.9M | $5.0M | ||
| Q2 25 | $-30.0M | $6.4M | ||
| Q1 25 | $-26.4M | $5.7M | ||
| Q4 24 | $-46.8M | $6.1M | ||
| Q3 24 | $-67.2M | $6.0M | ||
| Q2 24 | $-54.8M | $5.6M | ||
| Q1 24 | $-63.5M | $5.9M |
| Q4 25 | — | — | ||
| Q3 25 | 97.9% | — | ||
| Q2 25 | 99.1% | — | ||
| Q1 25 | 99.4% | — | ||
| Q4 24 | 99.6% | — | ||
| Q3 24 | 99.4% | — | ||
| Q2 24 | 99.5% | — | ||
| Q1 24 | 99.6% | — |
| Q4 25 | 42.1% | 36.6% | ||
| Q3 25 | -15.0% | 26.3% | ||
| Q2 25 | -65.0% | 35.3% | ||
| Q1 25 | -55.3% | 31.6% | ||
| Q4 24 | -96.5% | 34.2% | ||
| Q3 24 | -125.5% | 32.4% | ||
| Q2 24 | -128.4% | 31.9% | ||
| Q1 24 | -117.4% | 33.3% |
| Q4 25 | -31.0% | 26.5% | ||
| Q3 25 | 211.4% | 19.5% | ||
| Q2 25 | -116.8% | 25.8% | ||
| Q1 25 | -109.6% | 23.4% | ||
| Q4 24 | -174.4% | 25.9% | ||
| Q3 24 | -267.7% | 23.5% | ||
| Q2 24 | -233.1% | 23.6% | ||
| Q1 24 | -226.6% | 24.0% |
| Q4 25 | $0.09 | $0.63 | ||
| Q3 25 | $1.94 | $0.46 | ||
| Q2 25 | $-1.00 | $0.58 | ||
| Q1 25 | $-1.03 | $0.51 | ||
| Q4 24 | $-1.95 | $0.55 | ||
| Q3 24 | $-3.08 | $0.54 | ||
| Q2 24 | $-2.52 | $0.50 | ||
| Q1 24 | $-3.04 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | — |
| Total DebtLower is stronger | $44.7M | — |
| Stockholders' EquityBook value | $-271.1M | $338.6M |
| Total Assets | $226.8M | $2.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | — | ||
| Q3 25 | $3.5M | — | ||
| Q2 25 | $9.5M | — | ||
| Q1 25 | $18.5M | — | ||
| Q4 24 | $40.4M | — | ||
| Q3 24 | $44.8M | — | ||
| Q2 24 | $93.7M | — | ||
| Q1 24 | $52.9M | — |
| Q4 25 | $44.7M | — | ||
| Q3 25 | $34.2M | — | ||
| Q2 25 | $33.9M | — | ||
| Q1 25 | $33.6M | — | ||
| Q4 24 | $33.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-271.1M | $338.6M | ||
| Q3 25 | $-274.1M | $334.3M | ||
| Q2 25 | $-354.6M | $330.6M | ||
| Q1 25 | $-341.8M | $329.3M | ||
| Q4 24 | $-326.4M | $324.4M | ||
| Q3 24 | $-292.3M | $321.7M | ||
| Q2 24 | $-241.3M | $315.3M | ||
| Q1 24 | $-201.4M | $314.2M |
| Q4 25 | $226.8M | $2.6B | ||
| Q3 25 | $233.9M | $2.6B | ||
| Q2 25 | $185.2M | $2.6B | ||
| Q1 25 | $200.2M | $2.6B | ||
| Q4 24 | $226.3M | $2.7B | ||
| Q3 24 | $238.5M | $2.6B | ||
| Q2 24 | $292.4M | $2.6B | ||
| Q1 24 | $256.6M | $2.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.6M | $31.8M |
| Free Cash FlowOCF − Capex | — | $30.1M |
| FCF MarginFCF / Revenue | — | 116.2% |
| Capex IntensityCapex / Revenue | 0.0% | 6.7% |
| Cash ConversionOCF / Net Profit | — | 4.64× |
| TTM Free Cash FlowTrailing 4 quarters | — | $51.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.6M | $31.8M | ||
| Q3 25 | $-14.7M | $7.3M | ||
| Q2 25 | $-20.2M | $6.4M | ||
| Q1 25 | $-25.6M | $9.3M | ||
| Q4 24 | $-28.7M | $30.4M | ||
| Q3 24 | $-53.3M | $9.6M | ||
| Q2 24 | $-38.2M | $7.7M | ||
| Q1 24 | $-38.2M | $5.1M |
| Q4 25 | — | $30.1M | ||
| Q3 25 | — | $6.2M | ||
| Q2 25 | $-20.2M | $5.6M | ||
| Q1 25 | $-25.6M | $9.1M | ||
| Q4 24 | $-28.7M | $28.7M | ||
| Q3 24 | $-53.3M | $9.4M | ||
| Q2 24 | $-38.6M | $7.4M | ||
| Q1 24 | $-38.2M | $3.9M |
| Q4 25 | — | 116.2% | ||
| Q3 25 | — | 24.3% | ||
| Q2 25 | -78.7% | 22.8% | ||
| Q1 25 | -106.5% | 37.6% | ||
| Q4 24 | -107.0% | 121.1% | ||
| Q3 24 | -212.2% | 36.6% | ||
| Q2 24 | -164.4% | 31.2% | ||
| Q1 24 | -136.5% | 16.1% |
| Q4 25 | 0.0% | 6.7% | ||
| Q3 25 | 0.0% | 4.3% | ||
| Q2 25 | 0.0% | 3.0% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.3% | 7.2% | ||
| Q3 24 | 0.0% | 1.0% | ||
| Q2 24 | 2.0% | 1.0% | ||
| Q1 24 | 0.1% | 4.7% |
| Q4 25 | — | 4.64× | ||
| Q3 25 | -0.23× | 1.47× | ||
| Q2 25 | — | 1.00× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 4.96× | ||
| Q3 24 | — | 1.60× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | — | 0.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGEN
| Non Cash Royalty Revenue | $31.1M | 91% |
| Other | $3.2M | 9% |
BCML
Segment breakdown not available.
